The shares of one of the leading defense component manufacturers gained 3 percent on Monday after its subsidiary got approval to make printed circuit board assemblies.
At 3:20 p.m., The shares of DCX Systems were trading at a share price of Rs 305, up 3 percent from its previous close price and the company has a market capitalization of 2,858 Cr.
According to the company’s exchange filing, The company announced that Raneal Advanced Systems the subsidiary of DCX Systems had received approval for the production of printed circuit board assembly (PCBA), and the company commenced production of PCBs on September 25, 2023.
DCX systems have delivered multibagger returns of 110 percent in six months. A shareholder’s investment of Rs. 1 lakh in the company would be worth Rs. 2.10 lakhs after a six-month. and the stock has delivered 36 percent on a year-to-date basis.
DCX Systems revenue has decreased by 20 percent from 213 Cr in Q1FY23 to 170 Cr in Q1FY24, accompanied by profits of 5 Cr in Q1FY23 to 9 Cr in Q1FY24 which has increased by 80 percent.
The company has reported for the recent financial year a Return on equity of 12.69 percent, a Return on capital employed of 19.64 percent, and a debt-to-equity ratio of 0.89 percent.
According to the latest shareholding pattern, the company promoters hold 71.73 percent of the company, while Foreign institutional investors hold 0.69 percent and domestic institutional investors own a 9.29 percent stake.
DCX Systems provides end-to-end solutions for cable & wire harnesses, electronic subsystems, high-end System Integration, and PCB Assembly for the Defence and Aerospace Industries.
Written by Bharath K.S
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.